Bridgefront Capital’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Sell
51,351
-30,027
-37% -$323K 0.2% 170
2026
Q1
$688K Buy
81,378
+43,013
+112% +$471K 0.17% 202
2025
Q4
$433K Buy
+38,365
New +$475K 0.11% 303
2025
Q3
– Sell
-13,760
Closed -$194K – 594
2025
Q2
$194K Buy
+13,760
New +$245K 0.05% 547

Other funds holding BHVN

Bridgefront Capital's BHVN Position: Q2 2026 in Review

Bridgefront Capital reduced its Biohaven (BHVN) stake by 37% in Q2 2026, selling an estimated $323K and leaving 51,351 shares worth $764K. The position accounts for 0.2% of the portfolio, ranked #170.

Bridgefront Capital first reported a position in BHVN in Q2 2025 and has held it in 4 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Bridgefront Capital held 51,351 shares of Biohaven worth $764K as of Q2 2026.
  • Bridgefront Capital sold 30,027 Biohaven shares in Q2 2026, an estimated $323K.
  • Biohaven made up 0.2% of Bridgefront Capital's portfolio in Q2 2026, its #170 holding.
  • Bridgefront Capital first reported a position in Biohaven in Q2 2025 and has held it in 4 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.